FDA Inspection 1149291 — Belleview 402 LLC

Belleview 402 LLC — FEI 3005350897

The FDA completed an inspection of Belleview 402 LLC on August 20, 2021 in Brooksville, FL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 20, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Brooksville, FL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
117721 CFR 211.63Equipment Design, Size and Location
189021 CFR 211.165(e)Test methods
360321 CFR 211.160(b)Scientifically sound laboratory controls